Research, product development & scientific principles
How MVS Pharma develops and compares omega-3 — from raw material to sealed capsule, from source to public claim.
Research principles
MVS Pharma follows an evidence-oriented approach: every claim is verified, every source cited, every interpretation phrased neutrally. We distinguish between verified values, manufacturer statements, and missing public disclosures.
Source-based
Every claim references a verifiable source — CoA, lab document, manufacturer declaration, or public publication.
Neutral
No automatic overall winner, no ranking, no quality score. Products are compared, not scored.
Reference basis separate
91% omega-3 in oil and 92% rTG share stay separate everywhere. Source and reference basis are reported individually.
"Not public" ≠ "does not exist"
A value not publicly disclosed does not mean it does not exist or that quality is poor. We label this clearly.
Product development
MVS develops omega-3 as a complete system. Six stages — each affects the quality of the final product:
Raw material
Selection and identification of the raw oil — fish species, origin, freshness.
Concentration
Enrichment of omega-3 fatty acids EPA, DHA, and DPA in the oil.
Purification
Removal of contaminants and oxidation products.
Molecular form
rTG form for high bioavailability — transparently disclosed.
Capsule technology
Capsule material, format, and handling.
Individually sealed
Portion protection against oxidation — each capsule individually sealed.
Scientific principles in comparison
- •50 internal vs. 30 public criteria — internal fields are never published.
- •Exact product and variant identification — no mixing.
- •No automatic overall winner, no ranking, no quality score.
- •91% omega-3 in oil and 92% rTG share stay separate everywhere.
- •Source and reference basis are reported separately.
- •Filtered / comparison URLs and private content are noindex.